HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xuefeng Wang Selected Research

1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)

1/2014The inhibitory effects of Npas4 on seizures in pilocarpine-induced epileptic rats.
6/2012A new trick of INPP4A: decreased expression of INPP4A in patients with temporal lobe epilepsy and pilocarpine-induced rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xuefeng Wang Research Topics

Disease

96Neoplasms (Cancer)
01/2024 - 05/2002
82Epilepsy (Aura)
07/2023 - 01/2007
52Seizures (Absence Seizure)
07/2023 - 01/2008
31Temporal Lobe Epilepsy
01/2022 - 01/2008
27Hemorrhage
07/2023 - 03/2002
25Infections
12/2023 - 05/2004
19Thrombosis (Thrombus)
11/2023 - 11/2002
19Drug Resistant Epilepsy
01/2021 - 01/2009
18Status Epilepticus (Complex Partial Status Epilepticus)
02/2021 - 01/2014
15Hemophilia A (Haemophilia)
07/2023 - 03/2002
15Inflammation (Inflammations)
01/2023 - 06/2003
14Neoplasm Metastasis (Metastasis)
01/2023 - 02/2009
13Squamous Cell Carcinoma of Head and Neck
03/2024 - 08/2014
12Carcinoma (Carcinomatosis)
10/2023 - 05/2008
12Gout
01/2023 - 05/2015
9Asthma (Bronchial Asthma)
01/2023 - 09/2011
9Glioma (Gliomas)
01/2023 - 09/2006
8Melanoma (Melanoma, Malignant)
06/2023 - 01/2018
8Gallbladder Neoplasms (Gallbladder Cancer)
04/2022 - 06/2012
7COVID-19
12/2023 - 01/2020
7Ovarian Neoplasms (Ovarian Cancer)
11/2023 - 02/2014
7Venous Thrombosis (Deep-Vein Thrombosis)
05/2023 - 01/2017
6Venous Thromboembolism
10/2023 - 07/2011
6AIDS-Related Complex (ARC)
08/2023 - 11/2004
6Autoimmune Diseases (Autoimmune Disease)
02/2022 - 01/2015
6B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 12/2018
5Hepatocellular Carcinoma (Hepatoma)
11/2023 - 10/2008
5Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
10/2023 - 05/2015
5Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 12/2016
5Brain Diseases (Brain Disorder)
02/2021 - 04/2015
5Schistosomiasis (Bilharziasis)
10/2018 - 01/2010
4Hypertension (High Blood Pressure)
12/2023 - 01/2018
4Mitochondrial Diseases (Mitochondrial Disease)
11/2023 - 10/2008
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 06/2012
4Hemophilia B (Haemophilia B)
08/2023 - 01/2015
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 01/2018
4Hypersensitivity (Allergy)
01/2023 - 03/2016
4Dehydration (Water Stress)
06/2022 - 03/2006
4Lymphoma (Lymphomas)
12/2021 - 12/2018
4Acute Lung Injury
11/2021 - 01/2012
4Rupture
10/2020 - 02/2014
4Colonic Neoplasms (Colon Cancer)
01/2020 - 03/2016

Drug/Important Bio-Agent (IBA)

53Proteins (Proteins, Gene)FDA Link
01/2024 - 03/2006
40Pilocarpine (Ocusert)FDA LinkGeneric
01/2018 - 08/2010
37Biomarkers (Surrogate Marker)IBA
01/2024 - 04/2010
20Anticonvulsants (Antiepileptic Drugs)IBA
02/2021 - 01/2009
17CytokinesIBA
01/2024 - 06/2003
12AntigensIBA
02/2024 - 02/2009
12MicroRNAs (MicroRNA)IBA
01/2024 - 10/2015
12RNA (Ribonucleic Acid)IBA
01/2023 - 09/2010
12Messenger RNA (mRNA)IBA
01/2023 - 09/2011
12Factor VIII (Coagulation Factor VIII)IBA
10/2022 - 03/2002
11EnzymesIBA
12/2023 - 03/2006
11Pentylenetetrazole (Metrazol)IBA
07/2023 - 09/2014
11Peptides (Polypeptides)IBA
01/2023 - 09/2011
10Kainic Acid (Kainate)IBA
07/2023 - 12/2014
9DNA (Deoxyribonucleic Acid)IBA
01/2024 - 04/2014
9Immunoglobulin G (IgG)IBA
10/2023 - 04/2011
9AntibodiesIBA
10/2023 - 02/2009
9Long Noncoding RNAIBA
06/2022 - 01/2019
8Protein CIBA
11/2023 - 07/2011
8Immune Checkpoint InhibitorsIBA
10/2023 - 01/2018
8Small Interfering RNA (siRNA)IBA
01/2023 - 01/2015
8Uric Acid (Urate)IBA
01/2023 - 05/2015
8VaccinesIBA
11/2021 - 11/2010
7Glucose (Dextrose)FDA LinkGeneric
11/2023 - 10/2016
7Fibrinogen (Factor I)FDA Link
07/2023 - 06/2006
7Interleukin-10 (Interleukin 10)IBA
09/2021 - 01/2012
6ThrombinFDA Link
07/2023 - 06/2013
6Phosphotransferases (Kinase)IBA
01/2023 - 12/2015
6AntithrombinsIBA
01/2022 - 11/2002
6Valproic Acid (Depakote)FDA LinkGeneric
01/2021 - 05/2010
6LigandsIBA
01/2021 - 01/2013
6LithiumIBA
01/2017 - 08/2011
5Chimeric Antigen ReceptorsIBA
01/2024 - 01/2020
5Monoclonal AntibodiesIBA
10/2023 - 02/2009
5Therapeutic UsesIBA
08/2023 - 05/2012
5Factor IX (Coagulation Factor IX)FDA LinkGeneric
08/2023 - 01/2015
5Protein SIBA
05/2023 - 07/2011
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 10/2008
5Levetiracetam (Keppra)FDA LinkGeneric
12/2022 - 10/2015
5MercuryIBA
08/2022 - 11/2004
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
08/2022 - 08/2015
5Immunoglobulin M (IgM)IBA
01/2022 - 01/2020
5Lithium ChlorideIBA
10/2017 - 08/2010
4Indicators and Reagents (Reagents)IBA
03/2024 - 10/2012
4Interleukin-17 (Interleukin 17)IBA
10/2023 - 11/2011
4Blood Coagulation Factors (Coagulation Factor)IBA
05/2023 - 01/2019
4Oxygen (Dioxygen)IBA
04/2023 - 09/2014
4Cetuximab (Erbitux)FDA Link
01/2023 - 08/2014
4Fluorouracil (Carac)FDA LinkGeneric
01/2023 - 01/2015
4HydrogenIBA
08/2022 - 11/2004
4hydroxide ionIBA
06/2022 - 01/2005
4ImmunosorbentsIBA
01/2021 - 09/2010

Therapy/Procedure

51Therapeutics
01/2024 - 01/2009
18Drug Therapy (Chemotherapy)
10/2023 - 03/2005
16Immunotherapy
03/2023 - 01/2013
6Radiotherapy
01/2024 - 05/2014
4Lasers (Laser)
10/2023 - 03/2006
4Aftercare (After-Treatment)
01/2023 - 01/2015